NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amara Therapeutics

Amara Therapeutics

Private
IrelandHealthcare & Life Scienceshttps://www.amaratherapeutics.com/

Last Round

VC Round

Apr 23, 2025

Total Funding Raised

$3.29M

Company Overview

Amara Therapeutics is a digital health company that develops digital therapeutics and virtual care solutions for pelvic and bladder health conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

prescription digital therapeuticPDTxdigital healthtelemedicinepelvic healthurinary incontinenceoveractive bladderfemtechcognitive behavioral therapyCBTvirtual clinicbehavioral therapymedical device softwarepatient engagementdigital intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amara Therapeutics Comparables

Compare Amara Therapeutics with similar companies based on industry and business-model similarity.

Amara Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Renalis Health
88%
Axena Health
80%
Perifit
65%

Amara Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 23, 2025
SeedMay 8, 2023

Key People

Founding team and executive leadership

Emma Carr

Co-Founder and COO

Founding Team

Brendan Staunton

CEO Amara Therapeutics

Executive Team

Amara Therapeutics Investors

Notable investors and investment history

Amara Therapeutics investors
InvestorRounds
Western Development CommissionSeed
Enterprise IrelandSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 74% MoM, reaching 1.5K.

  • Sep 21, 2024

    Grew 60% QoQ from 5 to 8 employees.

Amara Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amara Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amara Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIreland
Employee Range11
Year Founded2021
Last FundingApr 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.